zami 1327 has been researched along with triiodothyronine in 1 studies
| Studies (zami 1327) | Trials (zami 1327) | Recent Studies (post-2010) (zami 1327) | Studies (triiodothyronine) | Trials (triiodothyronine) | Recent Studies (post-2010) (triiodothyronine) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 26,247 | 861 | 3,473 |
| Protein | Taxonomy | zami 1327 (IC50) | triiodothyronine (IC50) |
|---|---|---|---|
| Thyroid hormone receptor alpha | Homo sapiens (human) | 0.0006 | |
| Thyroid hormone receptor beta | Homo sapiens (human) | 0.0006 | |
| Proliferating cell nuclear antigen | Homo sapiens (human) | 3.6 | |
| Thyroid hormone receptor beta | Rattus norvegicus (Norway rat) | 0.0031 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.4109 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braga, M; Calovini, D; Mazzocchi, C; Mazzoleni, G; Presta, M; Ragnotti, G; Zavanella, T; Ziliani, S | 1 |
1 other study(ies) available for zami 1327 and triiodothyronine
| Article | Year |
|---|---|
Thyroid and chemical hepatocarcinogenesis: further insights from the hepatocarcinogen ZAMI 1305.
Topics: Animals; Carcinogens; Female; Hyperplasia; Liver Neoplasms, Experimental; Male; Organ Size; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Sex Factors; Thyroid Gland; Thyroidectomy; Triiodothyronine | 1984 |